Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01291797 · ClinicalTrials.gov registry record
Use of AEEG as Predictor of Long-term Motor Outcome in Neonates With Congenital Heart Disease
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Terminated
- Registry status
- 4
- Enrollment target
NCT01291797: Clinical Trial study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT01291797 is a clinical trial that was terminated before completion, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01291797 was terminated before completion, sponsored by Icahn School of Medicine at Mount Sinai.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
This study aims to examine performance on a neurological screening test, the Dubowitz, and sleep wake cycles on amplitude integrated electroencephalogram (AEEG) in neonates with congenital heart disease (CHD) as a way to potentially predict longterm motor outcome. It will compare the results of these studies to neonates without CHD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2010-07 |
| Est. Completion | 2011-06 |
Why NCT01291797 stopped before completion
NCT01291797 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01291797 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01291797 about?
NCT01291797 is a clinical study titled "Use of AEEG as Predictor of Long-term Motor Outcome in Neonates With Congenital Heart Disease". This study aims to examine performance on a neurological screening test, the Dubowitz, and sleep wake cycles on amplitude integrated electroencephalogram (AEEG) in neonates with congenital heart disease (CHD) as a way to potentially predict longterm motor outcome. It will compare the results of thes...
What is the current status of trial NCT01291797?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2010-07. Estimated completion is 2011-06.
Who is sponsoring clinical trial NCT01291797?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia